122 results on '"Ahluwalia M"'
Search Results
2. Integration of an App-Based Cognitive Evaluation Program into Radiosurgery Practice: Outcomes and Patient Survey Analysis from a Prospective Observational Study
3. A Comparison of Local Failure and Necrosis Following Different Radiosurgery Strategies for Large Brain Metastases
4. Characterization of Large Brain Metastases with 18F-Fluciclovine PET/CT Treated with Staged Stereotactic Radiosurgery (SSRS): Phase 1 Proof-of-Concept Interim Analysis
5. Results of a Phase I Trial of Dose Escalation for Preoperative Stereotactic Radiosurgery for Patients with Large Brain Metastases
6. Immune Checkpoint Inhibition and Single Fraction Stereotactic Radiosurgery in Non-Small Cell Lung Cancer Brain Metastases: An International Multicenter Study of 395 Patients
7. Stereotactic Radiosurgery for Small Intact Brain Metastasis: A Comparative Evaluation of 3 Different Single Fraction Prescription Doses
8. Three Decade Single-Institution Experience of Safety and Efficacy of Radiotherapy and Adjuvant Chemotherapy for Young Adult Patients with Medulloblastoma
9. P14.11.B A MULTICENTER STUDY OF LOW-INTENSITY FOCUSED ULTRASOUND WITH SYSTEMIC MICROBUBBLE OSCILLATORS FOR BLOOD-BRAIN BARRIER DISRUPTION FOR LIQUID BIOPSY IN GLIOBLASTOMA (LIBERATE)
10. Dedicated Isotropic 3-D T1 SPACE Sequence Imaging for Radiosurgery Planning Improves Brain Metastases Detection and Reduces the Risk of Intracranial Relapse
11. Pulsed Reduced Dose Rate (PRDR) Intensity Modulated Radiotherapy for Recurrent Primary Central Nervous System Malignancies: Dosimetric and Clinical Results
12. Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery is Not Associated with an Increased Risk of Radiation Necrosis: An International Multicenter Study of 657 Patients
13. P15.11.A 18F-Fluciclovine PET/CT to distinguish radiation necrosis from tumour progression in brain metastases treated with stereotactic radiosurgery: results of a prospective pilot study
14. Stable and Discriminatory Radiomic Features from the Tumor and Its Habitat Associated with Progression-Free Survival in Glioblastoma: A Multi-Institutional Study
15. Outcomes of Immune-Checkpoint Inhibitors (ICIs) and Stereotactic Radiosurgery (SRS) in Non-Small Cell Lung Cancer Brain Metastases (NSCLCBM) Patients
16. Outcomes of Immunotherapy (ICI) Alone vs. Stereotactic Radiosurgery (SRS) Alone vs. ICI and SRS Combined in Renal Cell Carcinoma Brain Metastasis
17. Neurocognitive Function Following Concurrent Radiotherapy and Temozolomide for Adult Patients With Low-Grade Glioma
18. Impact of Biological Sex on Survival Outcomes in Low-Grade Glioma
19. Concurrent vs. Sequential Stereotactic Radiosurgery and Immune Checkpoint Inhibition in Melanoma Brain Metastases: An International Cooperative Group Study
20. Outcomes of BRAF, MET, RET, and ROS1 Mutated Non-Small Cell Lung Cancer With Brain Metastases (NSCLCBM)
21. Outcomes of Immunotherapy (ICI) Alone vs. Stereotactic Radiosurgery (SRS) Alone vs. ICI and SRS Combined in Melanoma Brain Metastasis
22. Outcomes of BRAF Mutated vs. Wild Type Tumors in Melanoma Brain Metastasis
23. 18F-Fluciclovine PET/CT to Distinguish Radiation Necrosis From Tumor Progression in Brain Metastases Treated With Stereotactic Radiosurgery: Results of a Prospective Pilot Study
24. P19.06 Radiosurgery followed by Tumor Treating Fields for brain metastases (1-10) from NSCLC in the phase 3 METIS trial
25. Comparison Of Adjuvant Versus Salvage Therapy Among IDH Mutant Low-Grade Glioma
26. Patterns Of Care And Outcomes Analysis For Adult Patients With Newly Diagnosed Medulloblastoma: A 30-Year Single Institution Experience
27. 18F-Fluciclovine PET/CT to Distinguish Radiation Necrosis from Tumor Progression in Brain Metastases Treated with Stereotactic Radiosurgery
28. Sex-Specific Differences In Low Grade Glioma Presentation And Outcome
29. P2.01-63 Radiosurgery Followed by Tumor Treating Fields (TTFields) for Brain Metastases (1-10) from NSCLC in the Phase 3 METIS Trial
30. Radiosurgery followed by tumour treating fields (TTFields) for brain metastases (1-10) from NSCLC in the phase III METIS trial
31. Malignant Transformation of Adult Low Grade Glioma: Risk Factors and Outcomes in the Molecular Era
32. Quality of Life following Concurrent Radiotherapy and Temozolomide for Adult Patients with Low-Grade Glioma
33. Tumor Treating Fields and radiosurgery for supra- and/or infratentorial brain metastases (1-10) from NSCLC in the phase 3 METIS study
34. Phase III METIS study: Tumor treating fields (150 kHz) and radiosurgery for supra- and/or infratentorial brain metastases (1-10) from non-small cell lung cancer (NSCLC)
35. Use of an Adaptive Control Strategy for the Production of Exotoxin A from High Density Culture of Recombinant Escherichia coli
36. Stereotactic Radiosurgery with Concurrent HER2-directed Therapy is Associated with Improved Objective Response for Breast Cancer Brain Metastasis
37. Risk Factors for Progression of Low Grade Glioma Following Gross Total Resection and Observation in the Molecular Era
38. Early Objective Response as a Prognosticator for Final Objective Response and Survival following SRS for Brain Metastases Treated with Concurrent Systemic Therapy
39. Stereotactic Radiosurgery (SRS) with Immune Checkpoint Inhibitor Therapy (ICI) for Patients with Brain Metastasis (BM): The Impact of Timing and Sequencing
40. Salvage Stereotactic Radiosurgery is Associated with Improved Overall Survival Compared to Whole Brain Radiation in the Setting of Progressive Brain Metastases
41. P2.01-70 Tumor Treating Fields and Radiosurgery for Supra- and/or Infratentorial Brain Metastases (1-10) from NSCLC in the Phase 3 METIS Study
42. P05.83 Tumor Treating Fields and radiosurgery for supra- and/or infratentorial brain metastases (1–10) from NSCLC in the phase 3 METIS study
43. OS1.2 Stability of EGFR amplification in glioblastoma is differentially impacted based on therapeutic pressure
44. Integrating imaging modalities for diagnosing cardiac amyloidosis
45. Multi-institutional competing risks analysis of distant brain failure and salvage patterns after upfront radiosurgery without whole brain radiotherapy for brain metastasis
46. An Evaluation of Prognostic Factors of Elderly Patients With Low Grade Glioma
47. Personalized Radiosurgery for Brain Metastasis: Moving beyond Tumor Size in the Modern Stereotactic Radiosurgery Era
48. Optimizing Intracranial Disease Control for Breast Cancer Patients with HER2 Positive Brain Metastasis: Combining SRS and CNS-Penetrating HER2 Blockade Therapy
49. Use of Concurrent TKIs With SRS is Associated With an Increased Rate of Radiation Necrosis Among Patients With Renal Cell Carcinoma Brain Metastasis
50. The Risk of Radiation Necrosis Following Stereotactic Radiosurgery with Concurrent Systemic Therapies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.